Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
13.36
+0.01 (0.07%)
Apr 24, 2026, 2:39 PM EDT - Market open
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $387.7 million as of April 24, 2026. Its market cap has increased by 307.67% in one year.
Market Cap
387.70M
Enterprise Value
335.79M
1-Year Change
307.67%
Ranking
Category
Stock Price
$13.36
Market Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has increased from $289.30M to $387.70M, an increase of 34.01%. That is a compound annual growth rate of 2.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 387.40M | -14.89% |
| Dec 31, 2025 | 455.20M | 273.42% |
| Dec 31, 2024 | 121.90M | -38.50% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
| Mar 21, 2013 | 289.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 400.75M |
| Rocket Pharmaceuticals | 399.39M |
| Avalo Therapeutics | 381.75M |
| Prelude Therapeutics | 381.31M |
| Niagen Bioscience | 380.37M |
| Opus Genetics | 379.94M |
| X4 Pharmaceuticals | 379.14M |
| Ovid Therapeutics | 375.84M |